Genetic analysis for eosinophilic sinusitis and construction of its database

Genetic analysis for eosinophilic sinusitis and construction of its database - Genetic analysis for eosinophilic sinusitis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039137

Enrollment

Registered

2020-01-15

Start date

2020-01-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eosinophilic sinusitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with eosinophilic sinusitis by score and histopathology

Exclusion criteria

Exclusion criteria: Those currently receiving immunotherapy. Patients who have taken steroid oral treatment, or who have taken oral steroid therapy or infusion therapy within one month, those who have used steroid-containing immunosuppressants, or those who have used them within one month. Pregnant ones. Those who are cancer-carrying patients.

Design outcomes

Primary

Measure	Time frame
Genes and molecules assosiated with disease occurrence and prognosis	—

Secondary

Measure	Time frame
Predictive markers for recurrence,and novel molecules targeted for treatment	—

Countries

Japan

Contacts

Public Contactdaisuke murakami

Graduate School of Medical Sciences, Kyushu University Otorhinolaryngology

muradai@med.kyushu-u.ac.jp0926425668

Outcome results